GENinCode (LON:GENI) Announces Earnings Results

GENinCode (LON:GENI) announced its earnings results on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative net margin of 185.47% and a negative return on equity of 409.40%.

GENinCode Price Performance

LON:GENI traded down GBX 0.21 during trading hours on Tuesday, reaching GBX 0.66. 19,438,984 shares of the company’s stock were exchanged, compared to its average volume of 5,127,747. The company has a market capitalization of £4.97 million, a P/E ratio of -0.32 and a beta of 0.59. GENinCode has a 12 month low of GBX 0.64 and a 12 month high of GBX 4.90. The business’s 50-day simple moving average is GBX 0.88 and its two-hundred day simple moving average is GBX 0.99. The company has a quick ratio of 15.88, a current ratio of 0.93 and a debt-to-equity ratio of 117.74.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.